Rate My Professor Graham Lieschke

Internationally recognised for research into blood disorders and cancer using zebrafish and mice, Professor Lieschke exploits the model’s strengths in genetics, embryology, and in vivo cell imaging to study haemopoiesis, leukocyte development and function, innate immunity, inflammation regulation, host-pathogen responses, and tissue regeneration versus scarring. His Lieschke Group at ARMI uses zebrafish mutants and infection models to identify genes critical for white blood cell development. He has published over 100 scientific papers and co-edited two books, including “Late fetal hematopoietic failure results from ZBTB11 deficiency despite abundant HSC specification” (Blood Advances, 2023), “Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes” (Blood, 2023), “Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi-organ autoimmunity” (eJHaem, 2023), and “A nox2/cybb zebrafish mutant with defective myeloid cell reactive oxygen species production displays normal initial neutrophil recruitment to sterile tail injuries” (G3: Genes|Genomes|Genetics, 2024). Awards include the John Maynard Hedstrom Research Fellowship of the Cancer Council of Victoria, Howard Hughes Postdoctoral Research Fellowship for Physicians, Wellcome Trust Senior Research Fellowship, NHMRC Senior Research Fellowship, Ludwig Institute’s inaugural George Hodgson Medal for Medical Science, and Member of the Order of Australia (AM) in 2023.